🔗 Share this article

This year's prestigious award in medical science has been awarded for revolutionary findings that illuminate how the immune system attacks harmful infections while sparing the body's own cells.

A trio of esteemed scientists—from Japan Shimon Sakaguchi and US scientists Dr. Brunkow and Fred Ramsdell—received this accolade.

The research uncovered specialized "sentinels" within the immune system that eliminate malfunctioning defense cells capable of attacking the organism.

The findings are now paving the way for innovative therapies for autoimmune diseases and cancer.

These laureates will share a monetary award worth 11 million Swedish kronor.

Decisive Discoveries

"Their research has been essential for understanding how the immune system functions and the reason we do not all develop severe self-attack conditions," commented the chair of the Nobel Committee.

The trio's studies explain a core mystery: How does the defense system protect us from numerous invaders while leaving our healthy cells unharmed?

The immune system uses immune cells that scan for indicators of infection, including viruses and germs it has never encountered.

These cells utilize detectors—called receptors—that are generated randomly in countless variations.

This provides the defense network the capacity to fight a wide array of threats, but the unpredictability of the process inevitably creates immune cells that can attack the host.

Protectors of the Immune System

Researchers earlier knew that a portion of these problematic defense cells were destroyed in the immune organ—the site where white blood cells develop.

This year's award honors the discovery of regulatory T-cells—known as the body's "security guards"—which travel through the body to disarm other immune cells that assault the body's own tissues.

It is known that this process malfunctions in self-attack conditions such as juvenile diabetes, MS, and RA.

A Nobel panel added, "The findings have established a new field of investigation and spurred the creation of new therapies, for example for tumors and autoimmune diseases."

In cancer, regulatory T-cells block the system from attacking the growth, so studies are focused on lowering their numbers.

For autoimmune diseases, trials are testing increasing T-reg cells so the organism is not under attack. A similar approach could also be effective in reducing the risks of transplanted organ rejection.

Innovative Studies

Professor Shimon Sakaguchi, from Osaka University, performed experiments on mice that had their thymus removed, causing self-attack conditions.

He demonstrated that introducing defense cells from healthy mice could stop the illness—suggesting there was a mechanism for preventing immune cells from attacking the host.

Mary Brunkow, from the a research center in a US city, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were investigating an genetic autoimmune disease in mice and people that led to the discovery of a genetic factor critical for how regulatory T-cells function.

"The pioneering work has revealed how the immune system is kept in check by regulatory T cells, stopping it from mistakenly attacking the healthy cells," commented a prominent biological science specialist.

"The work is a striking illustration of how fundamental physiological study can have far-reaching implications for public health."